Specifications

Indications
The Nile SIR, Nile PAX and Nile CroCo stent systems are indicated for the treatment of patients with clinical symptoms of myocardial ischemia related to the pathological condition of de novo lesions in native coronary arteries located on bifurcation sites, excluding left main trunk.

The0 Nile CroCo stent system is also indicated for the treatment of patients with clinical symptoms of lower limb ischemia caused by bifurcation stenosis located below the knee.



Drug Paclitaxel
Coating Polymer-free
Dosage 2.5 µg/mm²
Drug Sirolimus
Polymer Biodegradable-polymer
Dosage 1.4 µg/mm²
Material Cobalt Chromium Alloy L605
Length 18 to 24 mm
Diameter See Table in “Ordering information”
Number of cells 7/8/6 or 9/10/8
Metal to artery ratio From 10 to 15%
Stent thickness 73 µm
Nominal pressure 8 atm
Rated Burst Pressure 14 atm
Guidewire compatibility 0.014"
Guiding catheter compatibility 6F